Journal
ARCHIVES OF OSTEOPOROSIS
Volume 17, Issue 1, Pages -Publisher
SPRINGER LONDON LTD
DOI: 10.1007/s11657-021-01055-9
Keywords
Total joint arthroplasty; Osteoporosis; Prevalence; Treatment; Meta-analysis
Categories
Funding
- National Natural Science Foundation of China [81772384, 81902242]
- China Postdoctoral Science Foundation [2019M663268]
- GuangDong Basic and Applied Basic Research Foundation [2021A1515010531, 2021A1515010621]
- Medical Science and Technology Planning Project of Zhuhai, China
Ask authors/readers for more resources
Patients awaiting total knee or hip arthroplasty (TKA/THA) are at a higher risk of osteoporosis due to age and gender. This study found a high prevalence of osteoporosis in patients undergoing joint arthroplasty, especially in postmenopausal females. However, the treatment rate for osteoporosis is low.
Purpose Due to age and gender, patients awaiting total knee or hip arthroplasty (TKA/THA) are at a higher risk of osteoporosis. In joint arthroplasty, low bone mineral density (BMD) is a risk factor for implant osseointegration, durability, and prosthesis complications. This study aims to investigate the prevalence and treatment rate of osteoporosis in patients undergoing total joint arthroplasty (TJA). Methods We applied a comprehensive literature search through PubMed, Cochrane Library, and EMBASE from inception to July 10, 2021, for studies investigating the prevalence and treatment rate of osteoporosis in TJA patients. The aggregated prevalence was calculated with the random-effects model, and the heterogeneity between studies was checked by Cochran's Q test and quantified by the I-2 statistic. We performed subgroup analyses and meta-regression analyses to determine the source of heterogeneity. Publication bias was assessed by a funnel plot and verified by Egger's test. Anti-osteoporosis treatment for TJA patients was described qualitatively and quantitatively. Results Of 4561 citations identified by the search strategy, 11 studies including 3462 patients were eligible for inclusion. The pooled prevalence of osteoporosis and osteopenia in TJA patients was 24.8% (95%CI: 14.1-37.2%) and 38.5% (95%CI: 29.3-48.0%), respectively. The prevalence of osteoporosis/osteopenia in TJA patients was 64.0% (95%CI: 45.8-80.3%). In terms of gender, the pooled prevalence of osteoporosis in males, females, and postmenopausal females were 5.5% (95%CI: 1.5-11.4%), 29.0% (95%CI: 18.3-41.1%), and 38.3% (95%CI: 13.2-67.1%), respectively. The treatment rate of osteoporosis in TJA patients was 32.9% (95%CI: 15.2-53.1%) by a random-effects model. Conclusions Osteoporosis is highly prevalent in patients undergoing TJA, especially in postmenopausal females. However, the treatment rate of osteoporosis is low. Considering the possibility of surgical complications, clinicians should strengthen their awareness of pre-operative BMD assessment and manage osteoporosis in high-risk patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available